Insider Transactions in Q2 2023 at Agile Therapeutics Inc (AGRX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2023
|
Geoffrey Gilmore Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,216
+37.41%
|
-
|
|
Jun 28
2023
|
Robert G Conway Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+49.95%
|
-
|
|
Jun 28
2023
|
Alfred Altomari Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,463
+32.48%
|
-
|
|
Jun 28
2023
|
Paul Korner Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+50.0%
|
-
|
|
Jun 28
2023
|
Amy Welsh Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+50.0%
|
-
|
|
Jun 08
2023
|
John W Hubbard Director |
BUY
Grant, award, or other acquisition
|
Direct |
935
+48.93%
|
-
|
|
Jun 08
2023
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
935
+48.93%
|
-
|
|
Jun 08
2023
|
Josephine Torrente Director |
BUY
Grant, award, or other acquisition
|
Direct |
935
+48.62%
|
-
|
|
Jun 08
2023
|
Sharon Barbari Director |
BUY
Grant, award, or other acquisition
|
Direct |
935
+48.98%
|
-
|
|
Jun 08
2023
|
Sandra Carson Director |
BUY
Grant, award, or other acquisition
|
Direct |
935
+48.98%
|
-
|